XML 56 R35.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stock Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stock Based Compensation [Abstract] |
Schedule of Option Activity | The Company had the following option activity during the year ended December 31, 2023 and 2022:
|  | Number of Options |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value $ |
Outstanding at January 1, 2022 |  |  | 783,547 |  |  | $ | 34.17 |  |  |  |  |  |  |  |  |
Granted |  |  | 862,938 |  |  | $ | 25.43 |  |  |  |  |  |  |  |  |
Exercised |  |  | (156,910 | ) |  | $ | 7.69 |  |  |  |  |  |  |  |  |
Expired or forfeited |  |  | (182,705 | ) |  | $ | 37.13 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 1,306,870 |  |  | $ | 31.14 |  |  |  | 2.7 |  |  | $ | 1,537,752 |
Granted |  |  | 426,703 |  |  | $ | 12.50 |  |  |  |  |  |  |  |  |
Exercised |  |  | (24,668 | ) |  | $ | 7.34 |  |  |  |  |  |  |  |  |
Expired or forfeited |  |  | (153,844 | ) |  | $ | 30.70 |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2023 |  |  | 1,555,061 |  |  | $ | 26.38 |  |  |  | 3.4 |  |  | $ | 1,046,481 |
Exercisable, December 31, 2023 |  |  | 586,274 |  |  | $ | 33.10 |  |  |  | 2.6 |  |  | $ | 239,110 |
Schedule of Total Options Outstanding | The table below reflects information for the total options outstanding at December 31, 2023
Range of Exercise Prices |  | Number of Options |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |
$4.20 to $10.00 |  |  | 108,044 |  |  |  | 4.3 |  |  | $ | 8.02 |
$10.00 to $20.00 |  |  | 851,751 |  |  |  | 3.8 |  |  | $ | 14.35 |
$20.00 to $40.00 |  |  | 247,284 |  |  |  | 2.7 |  |  | $ | 33.91 |
$40.00 to $60.00 |  |  | 247,723 |  |  |  | 2.6 |  |  | $ | 48.30 |
$60.00 to $96.70 |  |  | 100,259 |  |  |  | 2.7 |  |  | $ | 75.54 |
Total |  |  | 1,555,061 |  |  |  | 3.4 |  |  | $ | 26.38 |
The table below reflects information for the vested options outstanding at December 31, 2023.
Range of Exercise Prices |  | Number of Options |  |  | Weighted average remaining contractual life (years) |  |  | Weighted average exercise price |
$4.20 to $10.00 |  |  | 15,667 |  |  |  | 1.1 |  |  | $ | 7.54 |
$10.00 to $20.00 |  |  | 222,707 |  |  |  | 2.9 |  |  | $ | 14.34 |
$20.00 to $40.00 |  |  | 143,670 |  |  |  | 2.4 |  |  | $ | 31.79 |
$40.00 to $60.00 |  |  | 138,776 |  |  |  | 2.5 |  |  | $ | 49.36 |
$60.00 to $96.70 |  |  | 65,454 |  |  |  | 2.7 |  |  | $ | 75.80 |
Total |  |  | 586,274 |  |  |  | 2.6 |  |  | $ | 33.58 |
Schedule of Company’s Non-Vested Options | A summary of the status of the Company’s non-vested options as of December 31, 2023, and changes during the year ended December 31, 2023, is presented below.
Nonvested Options |  | Options |  |  | Weighted average exercise price |
Nonvested at January 1, 2022 |  |  | 1,056,187 |  |  | $ | 30.51 |
Granted |  |  | 426,703 |  |  | $ | 12.50 |
Vested |  |  | (381,992 | ) |  | $ | 31.61 |
Forfeited |  |  | (132,111 | ) |  | $ | 52.07 |
Nonvested at December 31, 2023 |  |  | 968,787 |  |  | $ | 22.03 |
Schedule of Restricted Stock Unit | The Company had the following restricted stock unit (“RSU”) activity during the years ended December 31, 2023 and 2022:
|  | Number of RSUs |  |  | Weighted average grant date fair value |  |  | Weighted average remaining contractual life (years) |
Outstanding at January 1, 2022 |  |  | 399,738 |  |  | $ | 52.99 |  |  |  |  |
Granted |  |  | 467,043 |  |  | $ | 25.69 |  |  |  |  |
Forfeited |  |  | (39,346 | ) |  | $ | 44.06 |  |  |  |  |
Shares issued |  |  | (29,945 | ) |  | $ | 59.41 |  |  |  |  |
Withheld and cancelled |  |  | (8,416 | ) |  | $ | 68.69 |  |  |  |  |
Outstanding at December 31, 2022 |  |  | 789,074 |  |  | $ | 36.95 |  |  |  | 2.0 |
Granted |  |  | 383,406 |  |  | $ | 12.30 |  |  |  |  |
Forfeited |  |  | (244,923 | ) |  | $ | 58.18 |  |  |  |  |
Vested and issued |  |  | (141,859 | ) |  | $ | 31.38 |  |  |  |  |
Withheld and cancelled |  |  | (42,489 | ) |  | $ | 32.47 |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 743,209 |  |  | $ | 18.62 |  |  |  | 1.7 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration